Net profit of Venmax Drugs & Pharmaceuticals rose 1460.00% to Rs 0.78 crore in the quarter ended March 2025 as against Rs 0.05 crore during the previous quarter ended March 2024. Sales reported to Rs 0.33 crore in the quarter ended March 2025. There were no Sales reported during the previous quarter ended March 2024.
For the full year,net loss reported to Rs 0.01 crore in the year ended March 2025 as against net profit of Rs 0.06 crore during the previous year ended March 2024. Sales reported to Rs 0.81 crore in the year ended March 2025. There were no Sales reported during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. | |
| Sales | 0.33 | 0 | 0 | 0.81 | 0 | 0 |
| OPM % | -72.73 | 0 | - | -129.63 | 0 | - |
| PBDT | 0.78 | 0.06 | 1200 | 0 | 0.09 | -100 |
| PBT | 0.78 | 0.06 | 1200 | -0.01 | 0.08 | PL |
| NP | 0.78 | 0.05 | 1460 | -0.01 | 0.06 | PL |
Powered by Capital Market - Live News